Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Laurie Kuestner

Vascular Surgery Idaho Falls, ID Medical Doctor

NPI 1235111261 CMS profile 100792

2860 Channing Way Ste 220, Idaho Falls, ID 83404

Open in the dashboard

General payments

$2,253

23 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$16,847 paid to institutions, not to them · program years 2019–2021

Through program year 2024, Laurie Kuestner of Idaho Falls, ID is reported in the CMS Open Payments database as having received $2,253 across 23 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $16,847 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 32nd percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $320 2
2023 General $386 6
2022 General $352 5
2021 General $23 1
2020 General $330 2
2019 General $843 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Laurie Kuestner
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Laurie Kuestner were reported at $0. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Laurie Kuestner Vascular Surgery median Middle half National median
2019 $843 $796 $226–$2,363 $163
2020 $330 $348 $118–$1,110 $114
2021 $23 $471 $158–$1,421 $132
2022 $352 $725 $222–$2,183 $149
2023 $386 $836 $257–$2,440 $160
2024 $320 $909 $252–$2,619 $164
2025 $0 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Silk Road Medical, Inc. $1,009 6 payments
  2. W. L. Gore & Associates, Inc. $440 3 payments
  3. Shockwave Medical, Inc $346 2 payments
  4. LeMaitre Vascular, Inc. $155 4 payments
  5. Bard Peripheral Vascular, Inc. $148 1 payment
  6. NuVasive, Inc. $57 1 payment
  7. Medtronic, Inc. $43 2 payments
  8. Itamar Medical Inc $24 1 payment
  9. AngioDynamics, Inc. $23 1 payment
  10. Cook Medical LLC $10 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $1,493 19 payments
  2. Travel and Lodging $760 4 payments
Products named General payments · program years 2019–2024
  1. ENROUTE Transcarotid Neuroprotection System Carotid Artery Disease $832 5 payments
  2. ENROUTE Transcarotid Stent System $832 5 payments
  3. ENHANCE Transcarotid Peripheral Access Kit $832 5 payments
  4. ENROUTE 0.014 Guidewire $832 5 payments
  5. Vascular Lithotripsy $183 1 payment
  6. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $176 1 payment
  7. ENROUTE Transcarotid Stent $176 1 payment
  8. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $164 1 payment
  9. GORE TAG Thoracic Branch Endoprosthesis $158 1 payment
  10. GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis $157 1 payment
  11. Other $584 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

207

Prescriptions dispensed, refills included

Drug cost

$30,636

Paid at the pharmacy, in all

Branded share of claims

58.9%

Brand-name drugs, not generics

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 27 $16,528
Xarelto Rivaroxaban Brand 24 $13,278
Atorvastatin Calcium Generic 42 $362
Cilostazol Generic 43 $289
Clopidogrel Clopidogrel Bisulfate Brand 71 $179

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.

Billing to Medicare

Part B · data year 2024 · 70 billing codes

Paid by Medicare

$168,396

Medicare's payments for the services billed

Medicare patients

1,933

Average age 76

Services billed

2,855

804 women, 1,129 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 53%
Arthritis 41%
Diabetes 36%
Chronic kidney disease 32%
Atrial fibrillation 27%
Heart failure 25%
COPD 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

23 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Idaho

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record